The Boston Pediatric Device Strategic Partner Challenge Submission Guidelines


Submission Guidelines

Application Process and Timeline

  • Click here to preview application questions.

  • Submit a quick application online at BostonPDC.org. Applications are due by 11:59 PM ET at October 20, 2017.

  • Once an application is submitted, a comprehensive review of each application will be conducted by the Boston Pediatric Device Consortium (BPDC), the Innovation and Digital Health Accelerator at Boston Children's Hospital (IDHA), and the partner organizations.

  • Finalists will be named by Friday, November 24, 2017.

  • Finalists meeting the criteria for federal funding, will be invited to a live Pitch event, where they will pitch their device in front of a panel of judges. Applicants must be available to pitch on December 6, 2017 to be considered for the award (arrangements can be made for remote pitch). If you do not receive specific details about the event, you are not to attend the Pitch event.

  • Winners will be selected and notified 1-2 weeks after the pitch event.


Application Terms

  • Application must include only non-confidential information. All information disclosed in the application will be considered non-confidential public information.

  • Company may not use Boston Children's Hospital or partner names and/or brands on website, marketing materials, etc.

  • From a legal perspective, applications do not create a contract or other relationship with Boston Children's Hospital or the strategic partners other than participation in the grant process.

  • If an award is granted, it is considered pending until the Boston Pediatric Device Consortium and/or strategic partner awarding the prize, is provided with more in-depth diligence items (such as an NDA) and execution of the term sheet.


Criteria for Pediatric Device Strategic Partner Challenge Award Selection

 

Meets FDA Pediatric Device Criteria

  • Must be a pediatric device, as defined by the FDA in accordance with section 201(h) of the Federal Food Drug & Cosmetic Act: "devices intended to be used for patients who are 21 years of age or younger at time of diagnosis or treatment".

  • Align with goal of PDC: Promote the development of pediatric medical devices, including devices developed originally for pediatric patients as well as existing adult devices adapted for pediatric use.


Team Qualifications

  • Project/Company leadership with potential to succeed in development and distribution of the technology - as demonstrated through leadership/project team description and/or bios that indicate prior pertinent experience.


Clinical Impact

  • Demonstration of a clear unmet need, indication of how the device meets this need and superiority to existing alternatives.


Market OpportunitY

  • Defined population that will benefit from the technology.


Business ModeL

  • Economic and growth plan that provides for long-term viability.
  • Reimbursement considerations (existing procedure/new procedure).
  • Likelihood of success and risk mitigation plan.


Plan for use of funds

  • Demonstrates a sound strategy for use of grant money and, if applicable, thoughtful leveraging of strategic partnership.


Defensible IP


IF APPLICABLE - Partner & Startup Fit/Match

  • Plan for partnering with one or more of the sponsoring device companies that leverages partner assets and competencies and aligns with the applicant device development plans.